February 26, 2018 / 5:32 PM / 4 months ago

BRIEF-Neumentum Confirms Type B Meeting With FDA

Feb 26 (Reuters) - Neumentum:

* NEUMENTUM CONFIRMS TYPE B MEETING WITH FDA AND ANNOUNCES NEW CHIEF MEDICAL AND SCIENTIFIC OFFICERS

* SAYS ‍MAY 8 TYPE B MEETING WITH FDA CONFIRMED TO DISCUSS CLINICAL DEVELOPMENT PROGRAM FOR LEAD PRODUCT CANDIDATE NTM-001 Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below